Timothy MBA - Landos Biopharma Principal Director

LABPDelisted Stock  USD 4.02  0.15  3.60%   

Insider

Timothy MBA is Principal Director of Landos Biopharma
Age 63
Phone540 218 1767
Webhttps://landosbiopharma.com

Landos Biopharma Management Efficiency

The company has return on total asset (ROA) of (0.3938) % which means that it has lost $0.3938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7067) %, meaning that it created substantial loss on money invested by shareholders. Landos Biopharma's management efficiency ratios could be used to measure how well Landos Biopharma manages its routine affairs as well as how well it operates its assets and liabilities.
Landos Biopharma currently holds 27 K in liabilities. Landos Biopharma has a current ratio of 8.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Landos Biopharma's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

INSIDER Age

MBA JDCardio Diagnostics Holdings
60
Meeshanthini DoganCardio Diagnostics Holdings
35
Anna MooreTranscode Therapeutics
62
Timur DoganCardio Diagnostics Holdings
36
Qiyong LiuTranscode Therapeutics
60
Robert DudleyTranscode Therapeutics
73
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia. Landos Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 46 people. Landos Biopharma (LABP) is traded on NASDAQ Exchange in USA and employs 19 people.

Management Performance

Landos Biopharma Leadership Team

Elected by the shareholders, the Landos Biopharma's board of directors comprises two types of representatives: Landos Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Landos. The board's role is to monitor Landos Biopharma's management team and ensure that shareholders' interests are well served. Landos Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Landos Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rebecca Mosig, Executive Development
Patrick Truesdell, Principal Officer
Timothy MBA, Principal Director
Jennifer Creel, Interim Officer
Josep DVM, Advisor
Fabio MD, Executive Officer
Gregory Oakes, CEO President

Landos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Landos Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Landos Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Landos Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Landos Stock

  0.69SSNLF Samsung ElectronicsPairCorr

Moving against Landos Stock

  0.83BKRKY Bank RakyatPairCorr
  0.83KO Coca Cola Aggressive PushPairCorr
  0.79TLK Telkom Indonesia TbkPairCorr
  0.79EC Ecopetrol SA ADR Sell-off TrendPairCorr
  0.78PPERY Bank Mandiri PerseroPairCorr
The ability to find closely correlated positions to Landos Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Landos Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Landos Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Landos Biopharma to buy it.
The correlation of Landos Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Landos Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Landos Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Landos Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Landos Stock

If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format